COVID-19

This early-stage study tested a new mRNA vaccine designed to protect against COVID-19. It involved 182 healthy adults and aimed to check the vaccine's safety and measure the body's immune response over one year. The study was terminated early, and its main goal was to gather init…

This study looked back at health records to see how well the updated 2024-2025 Pfizer/BioNTech COVID-19 vaccine protected people from getting sick with COVID-19. Researchers analyzed data from CVS MinuteClinic patients aged 5 and older who got tested for the virus and reported sy…

This study tested a drug called ensovibep, given as an injection, to treat adults with early COVID-19 symptoms who were not in the hospital. The main goals were to see if the drug could reduce the amount of virus in the body and, more importantly, prevent people from needing to g…

This early-stage study tested a single dose of lab-made antibodies (casirivimab+imdevimab) in children hospitalized due to COVID-19. The main goals were to see how long the drug stayed in their blood and to check for safety issues. The study was terminated early and only enrolled…

This study tested whether infusions of stem cells from donor fat tissue could help patients with COVID-19. Researchers compared the stem cell treatment against a placebo (dummy infusion) in 48 adults suspected of having COVID-19. The main goals were to see if the treatment reduce…

This study tested whether a low-dose oral medication called emetine could help treat COVID-19 symptoms and prevent severe outcomes like hospitalization. Researchers planned to give participants either emetine or a placebo pill for 10 days to compare results. The trial was termina…

This study tested whether adding the cancer drug imatinib to standard hospital care could help adults hospitalized with COVID-19. The goal was to see if the drug could reduce deaths by potentially blocking the virus and reducing severe lung inflammation. The trial was stopped ear…

This study tested whether a drug called tocilizumab could help adults hospitalized with severe COVID-19 pneumonia. The goal was to see if the drug, which calms an overactive immune system, could improve patients' health status and reduce the need for breathing support compared to…

This study aimed to see if adding an experimental oral antiviral pill, called ensitrelvir, to standard hospital care could help adults hospitalized with COVID-19 recover faster and improve their chances of survival. The trial compared the pill to a placebo (a dummy pill) in over …

This study aimed to see if adding the drug hydroxychloroquine to standard hospital care helped adults with COVID-19 get better faster. It compared patients who received the drug for five days to those who received only usual care. The trial was stopped early after enrolling only …

This study tested whether adding the drug ABX464 to standard COVID-19 care could reduce dangerous inflammation and prevent patients from developing severe breathing problems. It involved 509 adults aged 65+ or younger adults with risk factors like obesity or diabetes. The trial w…

This study tested whether adding an injectable form of aprepitant—a medication normally used to prevent nausea—to standard hospital care could help adults recently hospitalized with COVID-19. Researchers wanted to see if it helped patients get discharged sooner and prevented them…

This study tested a nasal spray called AD17002 to see if it could help adults with mild to moderate COVID-19 get better faster. About 180 participants were randomly assigned to receive either a placebo or one of two doses of the spray, in addition to standard care. The main goals…

This study tested a single shot of lab-made antibodies (casirivimab and imdevimab) to see if it could help prevent severe COVID-19 in high-risk children under 12. Researchers gave the shot to a small group of kids and tracked how long the drug stayed in their bodies and checked f…

This study tested whether a daily pill (Emtricitabine/Tenofovir) could prevent COVID-19 in healthcare workers at high risk of exposure. Over 1,300 participants were randomly assigned to receive either the pill or a placebo, in addition to standard safety measures like masks. The …

This study aimed to see if a 10-week exercise and breathing rehabilitation program could help people with Long COVID. Researchers tested 21 participants to see if the program could reduce symptoms like fatigue and shortness of breath, improve physical fitness, and enhance mental …

This study tested whether giving rural pharmacists video coaching helps them better counsel patients who are hesitant about COVID-19 vaccines, compared to just giving them standard training materials. Researchers worked with 16 pharmacies in rural areas to see if the coaching imp…

This study aimed to understand how COVID-19 affects people with cancer. Researchers screened 83 patients receiving cancer treatment to find out how many had the virus without showing symptoms. They also checked patients' blood to see how their immune systems responded to the infe…

This study tested a special wristband called the AirGo to monitor the breathing patterns of hospitalized COVID-19 patients who were breathing on their own. The goal was to see if the band could detect patterns that signal a patient's breathing is getting worse and might require a…